|  | Number | (%) |
---|---|---|---|
Age | (mean ± SD, years) | 52.10 ± 11.10 |  |
≤50 | 336 | 49.9 | |
> 50 | 338 | 50.1 | |
Stage | I | 290 | 43.1 |
II | 280 | 41.5 | |
III | 104 | 15.4 | |
Estrogen receptor | Negative | 231 | 34.3 |
Positive | 443 | 65.7 | |
Progesterone receptor | Negative | 288 | 42.7 |
Positive | 386 | 57.3 | |
Operation type | Conservation | 395 | 58.6 |
Mastectomy | 279 | 41.4 | |
Chemotherapy | None | 105 | 15.6 |
AC | 148 | 22.0 | |
AC-Taxans | 93 | 13.8 | |
FAC | 178 | 26.4 | |
TAC | 58 | 8.6 | |
Others | 92 | 13.6 | |
Initial hormone therapy | None | 195 | 28.9 |
Tamoxifen | 306 | 45.4 | |
Aromatase inhibitor | 173 | 25.7 |